Insider Transactions in Q4 2023 at Rhythm Pharmaceuticals, Inc. (RYTM)
Insider Transaction List (Q4 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 29
2023
|
Hunter C Smith Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+12.74%
|
$63,000
$6.88 P/Share
|
Dec 28
2023
|
Joseph Shulman Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
7,926
-100.0%
|
$396,300
$50.0 P/Share
|
Dec 28
2023
|
Joseph Shulman Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,800
+46.18%
|
$142,800
$21.38 P/Share
|
Dec 27
2023
|
Joseph Shulman Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
5,015
-81.66%
|
$250,750
$50.01 P/Share
|
Dec 27
2023
|
Joseph Shulman Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,400
+28.1%
|
$50,400
$21.38 P/Share
|
Dec 06
2023
|
Hunter C Smith Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-24.57%
|
$800,000
$40.0 P/Share
|
Dec 06
2023
|
Hunter C Smith Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+19.72%
|
$120,000
$6.88 P/Share
|
Dec 05
2023
|
Hunter C Smith Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,026
-10.27%
|
$245,910
$35.06 P/Share
|
Dec 05
2023
|
Hunter C Smith Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,026
+9.31%
|
$42,156
$6.88 P/Share
|
Nov 24
2023
|
Hunter C Smith Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,974
-15.16%
|
$384,090
$35.02 P/Share
|
Nov 24
2023
|
Hunter C Smith Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,974
+13.17%
|
$65,844
$6.88 P/Share
|
Nov 14
2023
|
Hunter C Smith Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,000
-16.35%
|
$360,000
$30.38 P/Share
|
Nov 14
2023
|
Hunter C Smith Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+14.05%
|
$72,000
$6.88 P/Share
|
Nov 14
2023
|
Jennifer Chien EVP, Head of North America |
SELL
Open market or private sale
|
Direct |
13,677
-100.0%
|
$437,664
$32.01 P/Share
|
Nov 14
2023
|
Jennifer Chien EVP, Head of North America |
BUY
Exercise of conversion of derivative security
|
Direct |
12,030
+46.8%
|
$72,180
$6.8 P/Share
|
Nov 14
2023
|
Joseph Shulman Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
27,890
-88.17%
|
$892,480
$32.07 P/Share
|
Nov 14
2023
|
Joseph Shulman Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,890
+46.86%
|
$167,340
$6.8 P/Share
|
Nov 09
2023
|
Jennifer Chien EVP, Head of North America |
SELL
Open market or private sale
|
Direct |
3,438
-42.44%
|
$92,826
$27.69 P/Share
|
Nov 09
2023
|
Jennifer Chien EVP, Head of North America |
BUY
Exercise of conversion of derivative security
|
Direct |
3,438
+40.34%
|
$20,628
$6.8 P/Share
|
Nov 08
2023
|
Jennifer Chien EVP, Head of North America |
SELL
Open market or private sale
|
Direct |
5,712
-52.41%
|
$159,936
$28.97 P/Share
|
Nov 08
2023
|
Jennifer Chien EVP, Head of North America |
BUY
Exercise of conversion of derivative security
|
Direct |
5,712
+43.7%
|
$34,272
$6.8 P/Share
|
Nov 03
2023
|
Jennifer Chien EVP, Head of North America |
SELL
Open market or private sale
|
Direct |
80
-4.63%
|
$2,240
$28.0 P/Share
|
Nov 03
2023
|
Jennifer Chien EVP, Head of North America |
BUY
Exercise of conversion of derivative security
|
Direct |
80
+4.43%
|
$480
$6.8 P/Share
|